Zhengyu Liu Selected Research

Zhengyu Liu Research Topics

Disease

4	Neoplasms (Cancer) 03/2016 - 08/2003
3	Sepsis (Septicemia) 01/2023 - 01/2022
2	Cardiomyopathies (Cardiomyopathy) 04/2023 - 01/2020
2	Reperfusion Injury 01/2022 - 01/2020
2	Carcinogenesis 09/2004 - 08/2003
1	Weight Loss (Weight Reduction) 02/2024
1	Colorectal Neoplasms (Colorectal Cancer) 11/2023
1	Bites and Stings (Sting) 01/2023
1	Muscular Atrophy (Muscle Atrophy) 01/2023
1	Pathologic Processes 01/2023
1	Hypoxia (Hypoxemia) 01/2022
1	Dysarthria (Spastic Dysarthria) 03/2021
1	Hemiplegia (Spastic Hemiplegia) 03/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020
1	Thromboembolism 01/2020
1	Coronary Thrombosis 01/2020
1	Myocardial Infarction 01/2020
1	Heart Diseases (Heart Disease) 01/2020
1	Infarction (Infarctions) 01/2020
1	ST Elevation Myocardial Infarction 04/2014
1	Type 2 Diabetes Mellitus (MODY) 01/2010
1	Breast Neoplasms (Breast Cancer) 08/2003

Drug/Important Bio-Agent (IBA)

2	radix ophiopogonis drug combination radix ginseng fructus schizandrae (Shen Mai)IBA 04/2023 - 01/2020
2	Beclin-1IBA 04/2023 - 01/2020
2	Caspase 3 (Caspase-3)IBA 04/2023 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2003
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
2	LipopolysaccharidesIBA 01/2022 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2013 - 08/2003
1	GoldIBA 02/2024
1	Immune Checkpoint InhibitorsIBA 11/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2023
1	Circular RNAIBA 01/2023
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2023
1	Mitochondrial DNA (mtDNA)IBA 01/2023
1	InterferonsIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	Adenosine Diphosphate (ADP)IBA 01/2022
1	Purinergic P2X7 ReceptorsIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	SodiumIBA 03/2021
1	Evans Blue (Blue, Evans)FDA Link 01/2020
1	Galectin 3 (LGALS3)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Sincalide FDA Link 01/2020
1	AntithrombinsIBA 01/2020
1	Saline SolutionIBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2016
1	Gefitinib (Iressa)FDA Link 03/2016
1	2- amino- 8- (4- (2- hydroxyethoxy)cyclohexyl)- 6- (6- methoxypyridin- 3- yl)- 4- methylpyrido(2,3- d)pyrimidin- 7(8H)- oneIBA 01/2013
1	Glucose (Dextrose)FDA LinkGeneric 01/2010
1	RGS ProteinsIBA 09/2004
1	CyclinsIBA 08/2003
1	Cyclin-Dependent Kinase Inhibitor p27IBA 08/2003
1	Tyrosine Kinase InhibitorsIBA 08/2003
1	ErbB Receptors (EGF Receptor)IBA 08/2003
1	CP-654577IBA 08/2003
1	AntibodiesIBA 08/2003
1	Mitogen-Activated Protein KinasesIBA 08/2003

Therapy/Procedure

1	Ligation 01/2022
1	Punctures 01/2022
1	Percutaneous Coronary Intervention 04/2014